|
Volumn 1, Issue 3, 2007, Pages 218-214
|
Novel promising therapeutic agents in multiple sclerosis.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
IMMUNOSUPPRESSIVE AGENT;
NEW DRUG;
ALLERGIC ENCEPHALOMYELITIS;
ANIMAL;
HUMAN;
MULTIPLE SCLEROSIS;
PATENT;
REVIEW;
TREATMENT OUTCOME;
ANIMALS;
ANTI-INFLAMMATORY AGENTS;
DRUGS, INVESTIGATIONAL;
ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MULTIPLE SCLEROSIS;
PATENTS AS TOPIC;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 60749108212
PISSN: 1872213X
EISSN: None
Source Type: Journal
DOI: 10.2174/187221307782418856 Document Type: Review |
Times cited : (9)
|
References (96)
|